ExoStemTech - Crunchbase Company Profile & Funding

Q: Who invested in ExoStemTech?

ExoStemTech has 5 investors including DSC Investment And IMM Investment.

Q: When was the last funding round for ExoStemTech?

ExoStemTech closed its last funding round on obfuscated from a Series B round.

Q: How much funding has ExoStemTech raised to date?

ExoStemTech has raised obfuscated.

Overview

ExoStemTech

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About ExoStemTech

CB Rank

120291

ExoStemTech is a biotechnology company that develops stem cell exosome therapeutics, plant exosomes, and anti-cancer drugs.

Founded

obfuscation

Private

Series B

Ansan, Inch'on-jikhalsi, South Korea

1-10

www.exostemtech.com

Biotechnology

Genetics

Health Care

Product Research

Funding Rounds

Series B

OBF

obfuscation

Series A

OBF

obfuscation

Details

Legal Name

ExoStemTech Co., Ltd.

Also Known As

엑소스템텍

Operating Status

Active

Company Type

For Profit

Phone Number

+82 31 400 3941

Contact Email

contact@exostemtech.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

CARTISOME®

An exosome-based therapeutic for osteoarthritis that contains stem cell-derived exosomes with anti-inflammatory and cartilage regeneration factors.

BEIGESOME®

A therapeutic agent targeting obesity, diabetes, and fatty liver diseases using exosome technology.

Research & Development

ExoStemTech is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - ExoStemTech	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - ExoStemTech	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - ExoStemTech	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - ExoStemTech	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - ExoStemTech	5	obfuscated obfuscation	—	Series B

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - ExoStemTech	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - ExoStemTech	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - ExoStemTech	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - ExoStemTech	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - ExoStemTech	5	obfuscated obfuscation	—	Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
DSC Investment	—	Series B - ExoStemTech	—
DSC Investment	—	Series B - ExoStemTech	—
DSC Investment	—	Series B - ExoStemTech	—
DSC Investment	—	Series B - ExoStemTech	—
DSC Investment	—	Series B - ExoStemTech	—